Alaska Permanent Fund Corp is 10% Owner at Vir Biotechnology, Inc. (VIR). They have made 2 open-market trades across 2 companies since 2013, most recently 2020-10-16.
CIK 0001582681
2 open-market purchases totalling $55.0M since 2013, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.